Generation Bio 

Yahoo Finance • 7 days ago

Weekly Buzz: CYTK Scores First FDA Approval, INSM Ends Rhinosinusitis Study, XOMA Acquires GBIO

(RTTNews) - The biotech industry witnessed several key events this week, including major FDA approvals, acquisitions, pivotal clinical trial results and setbacks. • A series of FDA approvals were announced during the week, with GSK, Haloz... Full story

Yahoo Finance • 11 days ago

XOMA Royalty Enters into Agreement to Acquire Generation Bio

- Acquisition provides XOMA Royalty with potential milestone and royalty payments under Generation Bio’s collaboration with Moderna - - Generation Bio’s cell-targeted lipid nanoparticles (ctLNP) delivery platform for small interfering RNA... Full story

Yahoo Finance • 2 months ago

Generation Bio Announces CEO Transition

• Geoff McDonough, MD to step down as CEO & President and become Chair of the Company’s Board of Directors • Current Chief Legal Officer Yalonda Howze, JD named Interim CEO & President CAMBRIDGE, MASS., Oct. 22, 2025 (GLOBE NEWSWIRE) -... Full story

Yahoo Finance • 4 months ago

Generation Bio’s SWOT analysis: ctLNP tech stock faces pivotal moment

Generation Bio Co. (NASDAQ:GBIO), a biotechnology company specializing in siRNA and CAR-T capabilities with a market capitalization of $42.4 million, finds itself at a critical juncture as it navigates through strategic restructuring and t... Full story

Yahoo Finance • 4 months ago

Top movers in Wednesday's session

Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session. [topmovers] TOP GAINERS TICKER CHANGE COMMENT WBTN [https://www.ch... Full story

Yahoo Finance • 4 months ago

Generation Bio soars as it explores strategic alternatives

[Man looking at currency trading app on his smart phone from his home office] Alistair Berg Generation Bio (NASDAQ:GBIO [https://seekingalpha.com/symbol/GBIO]) jumped 45% as the company announced it would review strategic alternatives. T... Full story

Yahoo Finance • 4 months ago

Wednesday's session: gap up and gap down stocks

The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session. [gap] GAP UP STOCKS TICKER CHANGE COMMENT BSLK [https://www.chartmill.com/stock/quote/BS... Full story

Yahoo Finance • 4 months ago

What's going on in today's pre-market session

As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. [premarket] TODAY'S PRE-MARKET GAINERS TICKER CHANGE CO... Full story

Yahoo Finance • 5 months ago

Generation Bio Announces 1-for-10 Reverse Stock Split

CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced that it will imple... Full story

Yahoo Finance • 5 months ago

West Virginia abortion ban upheld over drugmaker's challenge

(Reuters) -A divided federal appeals court on Tuesday upheld West Virginia’s near-total ban on abortion, including limits it imposed on access to the medication abortion drug mifepristone. The 4th U.S. Circuit Court of Appeals in Richmond... Full story

Yahoo Finance • 6 months ago

Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced that, on July 1, 20... Full story

Yahoo Finance • 7 months ago

Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference

CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D.... Full story

Yahoo Finance • 9 months ago

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

-  Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases -  Lead target and indication to be announced MY 2025 -  Cash balance of $185.2 million expected to fund o... Full story

Yahoo Finance • 2 years ago

Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms

Company to invest in highly selective cell-targeted lipid nanoparticle (ctLNP) delivery platform to develop wholly-owned programs for extrahepatic cell types Development of immune-quiet DNA (iqDNA) platform for lead hemophilia A program to... Full story

Yahoo Finance • 2 years ago

Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results

-  Immune-quiet DNA evades innate immune sensors in both mice and non-human primates addressing a central challenge for non-viral DNA therapeutics -  Proprietary cell-targeted LNP delivery system showed highly selective T cell transductio... Full story

Yahoo Finance • 2 years ago

Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform

70% of circulating and splenic T cells positive for mRNA expression in humanized mice with less than 8% delivery to off-target immune cells Stealth properties of cell-targeted lipid nanoparticle (ctLNP) platform confirmed in non-human pri... Full story

Yahoo Finance • 2 years ago

Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA

– Immune-quiet DNA (iqDNA) is a novel variant of closed-ended DNA (ceDNA) that evades host innate immune detection in both mice and non-human primates (NHPs) with a systemic cytokine profile and tolerability comparable to mRNA – Company i... Full story

Yahoo Finance • 2 years ago

Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit

CAMBRIDGE, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., preside... Full story

Yahoo Finance • 3 years ago

Generation Bio Reports Business Highlights and First Quarter 2023 Financial Results

Company entered into strategic collaboration with Moderna to use Generation Bio’s proprietary non-viral genetic medicine delivery system for two liver disease programs and to co-develop novel targeting for immune cells Factor VIII express... Full story

Yahoo Finance • 3 years ago

Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference 

CAMBRIDGE, Mass., April 11, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., preside... Full story